@article{524f3b2ea47440df99b0bb67fb96a1d6,
title = "Desacetyl-α-melanocyte stimulating hormone and α-melanocyte stimulating hormone are required to regulate energy balance",
abstract = " Objective: Regulation of energy balance depends on pro-opiomelanocortin (POMC)-derived peptides and melanocortin-4 receptor (MC4R). Alpha-melanocyte stimulating hormone (α-MSH) is the predicted natural POMC-derived peptide that regulates energy balance. Desacetyl-α-MSH, the precursor for α-MSH, is present in brain and blood. Desacetyl-α-MSH is considered to be unimportant for regulating energy balance despite being more potent (compared with α-MSH) at activating the appetite-regulating MC4R in vitro. Thus, the physiological role for desacetyl-α-MSH is still unclear. Methods: We created a novel mouse model to determine whether desacetyl-α-MSH plays a role in regulating energy balance. We engineered a knock in targeted QKQR mutation in the POMC protein cleavage site that blocks the production of both desacetyl-α-MSH and α-MSH from adrenocorticotropin (ACTH 1-39 ). Results: The mutant ACTH 1-39 (ACTH QKQR ) functions similar to native ACTH 1-39 (ACTH KKRR ) at the melanocortin 2 receptor (MC2R) in vivo and MC4R in vitro. Male and female homozygous mutant ACTH 1-39 (Pomc tm1/tm1 ) mice develop the characteristic melanocortin obesity phenotype. Replacement of either desacetyl-α-MSH or α-MSH over 14 days into Pomc tm1/tm1 mouse brain significantly reverses excess body weight and fat mass gained compared to wild type (WT) (Pomc wt/wt ) mice. Here, we identify both desacetyl-α-MSH and α-MSH peptides as regulators of energy balance and highlight a previously unappreciated physiological role for desacetyl-α-MSH. Conclusions: Based on these data we propose that there is potential to exploit the naturally occurring POMC-derived peptides to treat obesity but this relies on first understanding the specific function(s) for desacetyl-α-MSH and α-MSH.",
keywords = "Desacetyl-α-MSH, Obese mouse model, Obesity, POMC, α-MSH",
author = "Mountjoy, {Kathleen G.} and Alexandre Caron and Kristina Hubbard and Avik Shome and Grey, {Angus C.} and Bo Sun and Sarah Bould and Martin Middleditch and Beau Pontr{\'e} and Ailsa McGregor and Harris, {Paul W.R.} and Renata Kowalczyk and Brimble, {Margaret A.} and Rikus Botha and Tan, {Karen M.L.} and Piper, {Sarah J.} and Christina Buchanan and Syann Lee and Coll, {Anthony P.} and Elmquist, {Joel K.}",
note = "Funding Information: We thank J. Ross for help with MRI imaging analysis, K. Van Bysterveldt and M. Oudshoorn for help with mouse colony maintenance, harvesting tissues and preparing tissues for histology, K. Van Bysterveldt for help with cell culture and adenylyl cyclase assays, S. Amirapu and S. Cormack for help with histology, and E. Thorstensen for steroid hormone assays. We received funding from the following New Zealand and University of Auckland funding bodies: The Marsden Fund , Auckland Medical Research Foundation , Maurice and Phyllis Paykel Trust , Maurice Wilkins Centre for Biodiscovery and Faculty Research and Development Fund . We also thank the Program Project Grant Core and Mouse Metabolic Phenotyping Core at The University of Texas Southwestern Medical Center at Dallas (supported by NIH grants PL1DK081182 and UL1RR024923 ). This work was supported by NIH grant R37DK053301 to J.K.E. A.C is a Canadian Diabetes Association Post-doctoral Fellow. The work at Cambridge UK, was supported by Medical Research Council (MRC) (Award G108/617 ). A.P.C. was funded by the MRC Metabolic Disease Unit ( MRC_MC_UU_12012/1 ). K.M.T. was supported by the Agency for Science Technology and Research ( A*STAR ) Singapore. Funding Information: We thank J. Ross for help with MRI imaging analysis, K. Van Bysterveldt and M. Oudshoorn for help with mouse colony maintenance, harvesting tissues and preparing tissues for histology, K. Van Bysterveldt for help with cell culture and adenylyl cyclase assays, S. Amirapu and S. Cormack for help with histology, and E. Thorstensen for steroid hormone assays. We received funding from the following New Zealand and University of Auckland funding bodies: The Marsden Fund, Auckland Medical Research Foundation, Maurice and Phyllis Paykel Trust, Maurice Wilkins Centre for Biodiscovery and Faculty Research and Development Fund. We also thank the Program Project Grant Core and Mouse Metabolic Phenotyping Core at The University of Texas Southwestern Medical Center at Dallas (supported by NIH grants PL1DK081182 and UL1RR024923). This work was supported by NIH grant R37DK053301 to J.K.E. A.C is a Canadian Diabetes Association Post-doctoral Fellow. The work at Cambridge UK, was supported by Medical Research Council (MRC) (Award G108/617). A.P.C. was funded by the MRC Metabolic Disease Unit (MRC_MC_UU_12012/1). K.M.T. was supported by the Agency for Science Technology and Research (A*STAR) Singapore. Publisher Copyright: {\textcopyright} 2017 The Authors",
year = "2018",
month = mar,
doi = "10.1016/j.molmet.2017.11.008",
language = "English (US)",
volume = "9",
pages = "207--216",
journal = "Molecular Metabolism",
issn = "2212-8778",
publisher = "Elsevier GmbH",
}